Status of oncological care and epidemiology of prostate cancer in the republics of Central Asia
https://doi.org/10.17650/1726-9776-2016-12-3-82-86
Abstract
This article presents the data on the state of oncological care in patients with cancer, particularly prostate cancer in some countries of Central Asia – Republic of Uzbekistan, Kazakhstan and Kyrgyzstan. We have listed data on detectability during preventive examinations, morbidity, mortality, morphological verification, 1-year mortality, structure, distribution by stages, dispensary groups in patients with prostate cancer in these countries.
About the Authors
S. V. GolovachevRussian Federation
67 Prospekt Oktyabrya, Yaroslavl’, 150000
N. S. Nurgaliev
Kazakhstan
91 Prospekt Abaya, Almaty, 050022
Z. P. Kamarli
Russian Federation
44 Kievskaya St., Bishkek, 720000, Kyrgyz Republic
E. K. Makimbetov
Russian Federation
44 Kievskaya St., Bishkek, 720000, Kyrgyz Republic
References
1. Rebecca L. Siegel, Kimberly D. Miller and Ahmedin Jemal. Cancer statistics, 2015 //CA: A Cancer Journal for Clinicians. – V. 65 (1). – Р.5–29.
2. Herget K.A., Patel D.P., Hanson H.A., Sweeney C., Lowrance W.T. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. //Cancer Med. – 2016. – V. 5(1). – P.136-41.
3. Tao Z.Q., Shi A.M., Wang K.X., Zhang W.D. Epidemiology of prostate cancer: current status. //Eur Rev Med Pharmacol Sci. – 2015. – V.19 (5). – P.805-12.
4. Akaza H. Epidemiology and prevention. //Nihon Rinsho. – 2016. – V. 74(1). – P. 13-9.
5. Poulsen M.H., Dysager L., Gerke O., Lund L. Trends in prostate cancer in elderly in Denmark, 1980-2012. //Acta Oncol. – 2016. – V. 55 (sup1). – P. 74-78.
6. Capocaccia R., Foschi R., Zucchetto A., Valdagni R., Nicolai N., Maffezzini M., Gatta G. Estimates of prostate cancer burden in Italy. //Cancer Epidemiol. – 2015. – V.27 (40). – P.166-172.
7. Ruseckaite R., Beckmann K., O'Callaghan M., Roder D., Moretti K, Zalcberg J., Millar J., Evans S. Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. //BMC Res Notes. – 2016. – V. 22. – N.9 (1). – P.37.
8. Evans S.M., Millar J.L., Wood J.M., Davis I.D., Bolton D., Giles G. G., Frydenberg M., Frauman A., Costello A., McNeil J.J. The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer. //BJU Int. – 2013. – V. 111(4 Pt B). – P.158-66.
9. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015. рр. 56.
10. Guessous I., Cullati S., Fedewa S.A., Burton-Jeangros C., Courvoisier D.S., Manor O., Bouchardy C. Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities. //Prev Med. – 2016. – V. 82. – P.83-91.
11. Pakzad R., Mohammadian-Hafshejani A., Ghoncheh M., Pakzad I., Salehiniya H. The incidence and mortality of prostate cancer and its relationship with development in Asia. //Prostate Int. – 2015. – V. 3 (4). – P.135-40.
12. Оганесян М.Г. Основные показатели онкологической помощи населению стран СНГ: сравнительная оценка //Журнал «Медицинские новости». - №11, 2014. – С. 98-102.
13. Программа развития онкологической помощи в Республике Казахстан на 2012–2016 гг. http://www.aaror.org/jdownloads/nspr.rus.pdf
14. Статистика злокачественных новообразований в России и странах СНГ в 2012 г. Под редакцией Давыдова М.И., Аксель Е.М. М. 2014. – 225 с. // http://www.ronc.ru/attachments/article/2034/stat_2012.pdf
15. Cheng I., Witte J.S., McClure L.A., Shema S.J., Cockburn M.G., John E.M., Clarke C.A. Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. //Cancer Causes Control. – 2009. – V. 20 (8). – P.1431-40.
16. Chao G.F., Krishna N., Aizer A.A., Dalela D., Hanske J., Li H., Meyer C.P., et al. Asian Americans and prostate cancer: A nationwide population-based analysis. //Urol Oncol. – 2015. – V.22. – P. 1078-1439.
Review
For citations:
Golovachev S.V., Nurgaliev N.S., Kamarli Z.P., Makimbetov E.K. Status of oncological care and epidemiology of prostate cancer in the republics of Central Asia. Cancer Urology. 2016;12(3):82-86. https://doi.org/10.17650/1726-9776-2016-12-3-82-86